Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes

Diabetes Care

Volumn 23, Issue 4, 2000, Pages 524-528

  Targher, Giovanni ^a,b   Bertolini, Lorenzo ^a   Zenari, Luciano ^a   Cacciatori, Vittorio ^b   Muggeo, Michele ^b   Faccini, Giovanni ^b   Zoppini, Giacomo ^b,c  

^a SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HOMOCYSTEINE;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; VASCULAR DISEASE;

EID: 0034069666     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.4.524     Document Type: Article

References (35)

1. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274:1049-1057, 1995
2. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG: Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346:1395-1398, 1995
3. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230-236, 1997
4. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GHJ, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, deValk HW, Sales Luis AC, Parrot-Roulaud FM, Tan KS, Higgins I, Garcon D, Medrano MJ, Candito M, Evans AE, Andria G: Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA 277:1775-1781, 1997
5. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM: Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med 158:862-867, 1998
6. Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D'Agostino RB, Wolf PA, Jacques PF, Wilson PW: Nonfasting plasma total homocysteine levels and all-cause and cardiovascular mortality in elderly Framingham men and women. Arch Intern Med 159:1077-1080, 1999
7. Ridker PM, Manson JE, Buring JE, Shih J, Matias M, Hennekens CH: Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA 281:1817-1821, 1999
8. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJG, Jakobs C, Bouter LM, Heine RJ, Stehouwer CDA: Hyperhomocysteinemia is associated with increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 18:133-138, 1998
9. Taylor LM Jr, Moneta GL, Sexton GJ, Schuff RA, Poner JM: Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vasc Surg 29: 8-19, 1999
10. Stehouwer CD, Gall MA, Hougaard P, Jakobs C, Parving HH: Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria. Kidney Int 55:308-314, 1999
11. Nygård O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland PM, Kvale G: Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study. JAMA 274:1526-1533, 1995
12. Nygård O, Refsum H, Ueland PM, Vollset SE: Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 67:263-270, 1998
13. Agardh CD, Agardh E, Andersson A, Hultberg B: Lack of association between plasma homocysteine levels and microangiopathy in type 1 diabetes mellitus. Stand J Clin Lab Invest 54:637-641, 1994
14. Chico A, Perez A, Cordoba A, Arcelus R, Carreras G, de Leiva A, Gonzales-Sastre F, Blanco-Vaca F: Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia 41:684-693, 1998
15. Robillon JF, Canivet B, Sadoul JL, Jullien D, Morand P, Chambon P, Freychet P: Type 1 diabetes mellitus and homocysteine. Diabetes Metab 20:494-496, 1994
16. Cronin CC, McPartlin JM, Barry DG, Ferriss JB, Scott JM, Weir DG: Plasma homocysteine concentrations in patients with type 1 diabetes. Diabetes Care 21:1843-1847, 1998
17. Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Fiehn W, Ziegler R, Wahl P, Nawroth PP: Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care 20: 1880-1886, 1997
18. 1C. Diabetes 27: 102-107, 1978
19. Refsum H, Ueland PM, Svardal AM: Fully automated fluorescence assay for determining total homocysteine in plasma. Clin Chem 35:1921-1927, 1989
20. Stephenson J, Fuller JH, the EURODIAB IDDM Complications Study Group: Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37: 278-285, 1994
21. Lloyd CE, Stephenson J, Fuller JH, Orchard TJ: A comparison of renal disease across two continents: the Epidemiology of Diabetes Complications Study and the EURODIAB IDDM Complications Study. Diabetes Care 19:219-225, 1996
22. Wilcken DE: Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular disease. J Cardiovasc Risk 5:217-221, 1998
23. Blom HJ: Determinants of plasma homocysteine. Am J Clin Nutr 67:188-189, 1998
24. Bergmark C, Mansoor MA, Svardal A, de Faire U: Redox status of plasma homocysteine and related aminothiols in smoking and nonsmoking young adults. Clin Chem 43:1997-1999, 1997
25. Mansoor MA, Kristensen O, Hervig T, Drablos PA, Stakkestad JA, Woie L, Hetland O, Osland A: Low concentrations of folate in serum and erythrocytes of smokers: methionine loading decreases folate concentrations in serum of smokers and non-smokers. Clin Chem 43:2192-2194, 1997
26. Ortega RM, Lopez-Sobaler AM, Gonzales-Gross MM, Redondo RM, Marzana I, Zamora MJ, Andres P: Influence of smoking on folate intake and blood folate concentrations in a group of elderly Spanish men. J Am Coll Nutr 13:68-72, 1994
27. 12. Am J Clin Nutr 60:559-566, 1994
28. Raitakari OT, Porkka KVK, Rasanen L, Viikari JSA: Relations of life-style with lipids, blood pressure and insulin in adolescents and young adults: the Cardiovascular Risk in Young Finns Study. Atherosclerosis 111: 237-246, 1994
29. Targher G, Alberiche M, Zenere BM, Bonadonna RC, Muggeo M, Bonora E: Cigarette smoking and insulin resistance in patients with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:3619-3624, 1997
30. Vaccaro O, Ingrosso D, Rivellese A, Greco G, Riccardi G: Moderate hyperhomocysteinaemia and retinopathy in insulin-dependent diabetes. Lancet 349:1102-1103, 1997
31. Smulders YM, Rakic M, Slaats EH, Treskes M, Sijbrands EJ, Odekerken DA, Stehouwer CD, Silberbusch J: Fasting and post-methionine homocysteine levels in NIDDM: determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care 22:125-132, 1999
32. Lanfredini M, Fiorina P, Peca MG, Veronelli A, Mello A, Astorri E, Dall'Aglio P, Craveri A: Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus patients. Metabolism 47:915-921, 1998
33. Sawicki PT, Bender R, Didjurgeit U, Heinemann L, Muhlhauser I, Berger M: Smoking is associated with progression of diabetic nephropathy. Diabetes Care 17:126-131, 1994
34. Chaturvedi N, Stephenson JM, Fuller JH: The relationship between smoking and microvascular complications in the EURODIABIDDM Complications Study. Diabetes Care 18:785-792, 1995
35. Muhlhauser I, Bender R, Bott U, Jorgens V, Grusser M, Wagener W, Overmann H, Berger M: Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes. Diabet Med 13:536-543, 1996